F. NO. 8 (8)/2005/DP/NPPA-Div.II
GOVERNMENT OF INDIA
MINISTRY OF CHEMICALS AND FERTILIZERS
NATIONAL PHARMACEUTICAL PRICING AUTHORITY
NEW DELHI, DATED THE 15/6/2005
ORDER
In exercise of the powers, conferred by sub-paragraph (1)/(2)/(4) of paragraph 8 of the Drugs (Price Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority hereby fixes/revises the prices as specified in column (7) of the Table hereto annexed as the retail price/revised retail price, exclusive of local tax if any, in relation to each of the formulations specified in the corresponding entry in column (2) of the said Table with pack size specified in the corresponding entries in column (3) thereof;
TABLE
| Sl. No. | Name of the Formulation | Pack Size | Existing Retail Price (Rs.) | Retail Price without Excise Duty | Excise Duty (Rs.) | Revised Retail Price with Excise Duty (Rs.) |
|---|---|---|---|---|---|---|
| 1 | Monocomponent Insulin Huminsulin NPH U 100 Cartridge (Human Insulin) Batch No. FF4AJ3G – 5350 Cartridge Batch No. FF4S18E – 125 Cartridge Batch No. FF4V97F – 2375 Cartridge |
3ml Cartridge | — | 208.94 | 0.00 | 208.94 |
| 2 | Monocomponent Insulin Humaject 30/70 U 100 cartridge (Human Insulin) Each ml of 30% Neutral Insulin Solution & 70% Isophane Suspension Human Contians: 100 IUHuman Insulin Ph. Eur. (r-DNA origin) as active ingredient (B.No. FF4BJ1C / Qty. 2495Cartridges) (B.No. FF4BJ1C / Qty.5000 Cartridges) |
3ml Cartridge | — | 261.18 | 0.00 | 261.18 |
| 3 | Monocomponent Insulin Humaject Regular 100IU cartridge (Human Insulin) Each ml of Humaject-R-Insulin contains 100 IUHuman Insulin Ph. Eur. (r-DNA origin) as active ingredient (B.No. FF4BP1C / Qty. 5140 Cartridges) |
3ml Cartridge | — | 261.18 | 0.00 | 261.18 |
| 4 | Monocomponent Insulin Huminsulin Regular U100 Cartridge (Human Insulin) Each ml contains: 100 IU Human Insulin Ph. Eur. (r-DNA origin) as active ingredient (B.No. FF4AH8A / Qty. 1500Cartridges) (B.No. FF4AB1F / Qty. 3500Cartridges) |
3ml Cartridge | — | 208.94 | 0.00 | 208.94 |
| 5 | Monocomponent Insulin Huminsulin 30/70 U 100 Cartridge (Human Insulin) Batch No. FF4Z36A- 80,000 Cartridge Batch No. FF4X55C- 75,000 Cartridge Batch No. FF4AP2B- 70,000 Cartridge |
3ml Cartridge | — | 208.94 | 0.00 | 208.94 |
| 6 | Monocomponent Insulin Huminsulin NPH U 100 Cartridge (Human Insulin) Batch No. FF4AJ3A – 5000 Cartridge |
3ml Cartridge | — | 208.94 | 0.00 | 208.94 |
| 7 | Monocomponent Insulin Huminsulin 30/70 U 100 cartridge (Human Insulin) Each ml of 30% Neutral Insulin Solution & 70% Isophane Suspension Human Contians: 100 IUHuman Insulin Ph. Eur. (r-DNA origin) as active ingredient (B.No. FF4AP3G / Qty. 74420 Cartridges) |
3ml Cartridge | — | 208.94 | 0.00 | 208.94 |
| 8 | Monocomponent Insulin Huminsulin Regular 100IU cartridge (Human Insulin) Each ml of Humaject-R-Insulin contains 100 IUHuman Insulin Ph. Eur. (r-DNA origin) as active ingredient (B.No. FF4AH8A / Qty. 6315 Cartridges) (B.No. FF4BM2H / Qty. 1185 Cartridges) |
3ml Cartridge | — | 208.94 | 0.00 | 208.94 |
| 9 | Monocomponent Insulin Humalog U100 Cartridge (Human Insulin) Each ml contains: Insulin Lispro (r-DNA origin) 100IU (3.5 mg) as active ingredient (B.No. FF4DA1D / Qty. 10000 cartridges) (B.No. FF4Z93E / Qty. 3430 cartridges) (B.No. FF5D25E / Qty. 5070 cartridges) |
3ml Cartridge | — | 408.62 | 0.00 | 408.62 |
| 10 | Monocomponent Insulin Humaject 30/70 U 100 cartridge (Human Insulin) Each ml of 30% Neutral Insulin Solution & 70% Isophane Suspension Human Contians: 100 IUHuman Insulin Ph. Eur. (r-DNA origin) as active ingredient (B.No. FF5C58C / Qty. 12505 Cartridges) |
3ml Cartridge | — | 261.18 | 0.00 | 261.18 |
2. This order shall be applicable if the manufacturer of the formulation specified in column (2) of the Table above has complied with the requirements, if any, of
(a) the Drugs and Cosmetics Act, 1940 (23 of 1940) and the rules made thereunder; and
(b) the Industries (Development and Regulation) Act, 1951 (65 of 1951) as amended from time to time.
3.(a) The prices fixed/revised are the maximum retail prices (inclusive of excise duty and exclusive of local taxes, if any) for the specified pack and packs of similar strength, and companies cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(b) For different packing material used or any special feature claimed, companies are required to approach NPPA for approval/fixation of specific prices.
4. These prices/revised prices shall be made effective within 15 days of receipt of this order as required under sub para 14(1) of DPCO, 1995. The necessary price-list should also be issued as required under sub-paragraph (3) of paragraph 14 of the Drugs (Prices Control) Order, 1995.
(A. K. PAL)
Dy. Director
PN/81/2005/F
M/s Eli-Lilly and company (India) Pvt. Ltd.
Plot No. 92, Sector-32
Gurgaon-122001
Haryana
Last Page Updated: 07-06-2019
